Visualitzant per títol
Ara mostrant els elements 6819-6838 d 9798
-
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors
(Springer Nature, 2023-06) -
Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer
(American Association for Cancer Research, 2024-02-15) -
Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer
(Oxford University Press, 2023-12) -
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164
(American Society of Clinical Oncology, 2020-01-01) -
Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05)
(American Society of Clinical Oncology, 2023-10-01) -
Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer
(American Society of Clinical Oncology, 2019-05-01)